207 related articles for article (PubMed ID: 28654015)
1. LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma.
Knecht H; Mai S
Viruses; 2017 Jun; 9(7):. PubMed ID: 28654015
[TBL] [Abstract][Full Text] [Related]
2. Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.
Knecht H; Johnson NA; Haliotis T; Lichtensztejn D; Mai S
Lab Invest; 2017 Jul; 97(7):772-781. PubMed ID: 28436953
[TBL] [Abstract][Full Text] [Related]
3. The Use of 3D Telomere FISH for the Characterization of the Nuclear Architecture in EBV-Positive Hodgkin's Lymphoma.
Knecht H; Mai S
Methods Mol Biol; 2017; 1532():93-104. PubMed ID: 27873269
[TBL] [Abstract][Full Text] [Related]
4. LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.
Lajoie V; Lemieux B; Sawan B; Lichtensztejn D; Lichtensztejn Z; Wellinger R; Mai S; Knecht H
Blood; 2015 Mar; 125(13):2101-10. PubMed ID: 25568351
[TBL] [Abstract][Full Text] [Related]
5. 3D Telomere FISH defines LMP1-expressing Reed-Sternberg cells as end-stage cells with telomere-poor 'ghost' nuclei and very short telomeres.
Knecht H; Sawan B; Lichtensztejn Z; Lichtensztejn D; Mai S
Lab Invest; 2010 Apr; 90(4):611-9. PubMed ID: 20142802
[TBL] [Abstract][Full Text] [Related]
6. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
[TBL] [Abstract][Full Text] [Related]
7. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
8. 3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells.
Knecht H; Brüderlein S; Mai S; Möller P; Sawan B
Ann Anat; 2010 Sep; 192(5):302-8. PubMed ID: 20810259
[TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
[TBL] [Abstract][Full Text] [Related]
10. Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin's Lymphoma.
Knecht H; Righolt C; Mai S
Cancers (Basel); 2013 Jun; 5(2):714-25. PubMed ID: 24216998
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM
J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Epstein-Barr virus strains and variants in classical Hodgkin's lymphoma by laser microdissection.
García-Cosío M; Santón A; Martín P; Reguero ME; Cristóbal E; Bellas C
Histol Histopathol; 2008 Feb; 23(2):209-17. PubMed ID: 17999377
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
Oudejans JJ; Jiwa NM; Meijer CJ
J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
[TBL] [Abstract][Full Text] [Related]
14. 3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps".
Knecht H; Brüderlein S; Wegener S; Lichtensztejn D; Lichtensztejn Z; Lemieux B; Möller P; Mai S
BMC Cell Biol; 2010 Dec; 11():99. PubMed ID: 21144060
[TBL] [Abstract][Full Text] [Related]
15. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease.
Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T
Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680
[TBL] [Abstract][Full Text] [Related]
16. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
19. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
Reynolds DJ; Banks PM; Gulley ML
Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of major histocompatibility complex class I and LMP1 in Epstein-Barr virus-positive Hodgkin's lymphoma in a pediatric age group.
Aybar A; Krause JR
Microsc Res Tech; 2005 Nov; 68(3-4):247-9. PubMed ID: 16276512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
